glp 1 gip 1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Understand GLP-1/GIP Dual Agonist Tirzepatide

doi: 10.1007/s00125-017-4447-4 76 LynggaardMBGasbjergLSChristensenMBKnopFK

These compounded drugs have not been studied by the FDA for safety or efficacy

Moreover, almost all of this research comes from a handful of high-income countries, even as uptake of these drugs is increasing globally and the burden of cancer has disproportionately grown in lower-income countries

GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) are FDA-approved prescription drugs that contain synthetic GLP-1 receptor agonists

The American Diabetes Association (ADA) recommends [archived link] GLP-1 RAs as first-choice Type 2 diabetes medication options in many cases

Sign up for free today.